We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+7.06%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$2.66B
AUM Growth
+$447M
Cap. Flow
+$395M
Cap. Flow %
14.87%
Top 10 Hldgs %
18.05%
Holding
1,302
New
172
Increased
969
Reduced
51
Closed
109

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$18.9M
2
MSFT icon
Microsoft
MSFT
+$13.5M
3
AAPL icon
Apple
AAPL
+$12.1M
4
XOM icon
ExxonMobil
XOM
+$7.45M
5
META icon
Meta Platforms (Facebook)
META
+$7.29M

Sector Composition

Rank Sector Weight
1 Technology 21.37%
2 Healthcare 13.73%
3 Consumer Discretionary 11.89%
4 Financials 11.87%
5 Industrials 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRC
1101
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$87K ﹤0.01%
2,152
+1,034
+92% +$42.8K
MNTA
1102
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$86K ﹤0.01%
+3,278
New +$88.6K
GDS icon
1103
GDS Holdings
GDS
$6.34B
$85K ﹤0.01%
2,430
+387
+19% +$13.9K
GERN icon
1104
Geron
GERN
$911M
$85K ﹤0.01%
+48,062
New +$210K
HSII
1105
DELISTED
Heidrick & Struggles
HSII
$83K ﹤0.01%
+2,445
New +$95.2K
KPTI icon
1106
Karyopharm Therapeutics
KPTI
$168M
$83K ﹤0.01%
+324
New +$89.6K
CTMX icon
1107
CytomX Therapeutics
CTMX
$705M
$82K ﹤0.01%
+4,431
New +$101K
RTEC
1108
DELISTED
Rudolph Technologies Inc
RTEC
$82K ﹤0.01%
3,350
+2,169
+184% +$59.7K
CHRS icon
1109
Coherus Oncology
CHRS
$217M
$79K ﹤0.01%
+4,767
New +$84.5K
XNCR icon
1110
Xencor
XNCR
$1.44B
$78K ﹤0.01%
+2,004
New +$81.7K
MNR
1111
DELISTED
Monmouth Real Estate Investment Corp
MNR
$78K ﹤0.01%
4,675
+1,578
+51% +$26.6K
ACLS icon
1112
Axcelis
ACLS
$4.12B
$77K ﹤0.01%
3,897
+1,332
+52% +$27.4K
TVTX icon
1113
Travere Therapeutics
TVTX
$5.33B
$76K ﹤0.01%
+2,631
New +$75.2K
RPAI
1114
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
$76K ﹤0.01%
6,243
+198
+3% +$2.49K
ABEO icon
1115
Abeona Therapeutics
ABEO
$345M
$75K ﹤0.01%
+233
New +$82.7K
VSI
1116
DELISTED
Vitamin Shoppe Inc.
VSI
$75K ﹤0.01%
+7,542
New +$77.8K
CCRN
1117
DELISTED
Cross Country Healthcare
CCRN
$74K ﹤0.01%
8,448
+4,626
+121% +$47.2K
ARQL
1118
DELISTED
Arqule Inc
ARQL
$72K ﹤0.01%
+12,694
New +$72.2K
CDNA icon
1119
CareDx
CDNA
$1.92B
$71K ﹤0.01%
+2,456
New +$46K
FATE icon
1120
Fate Therapeutics
FATE
$281M
$71K ﹤0.01%
+4,378
New +$51.8K
HVT icon
1121
Haverty Furniture Companies
HVT
$401M
$71K ﹤0.01%
3,232
+2,078
+180% +$44.9K
HWKN icon
1122
Hawkins
HWKN
$2.91B
$71K ﹤0.01%
+3,420
New +$67.6K
NVTA
1123
DELISTED
Invitae Corporation
NVTA
$71K ﹤0.01%
+4,258
New +$48.5K
REX icon
1124
REX American Resources
REX
$1.46B
$65K ﹤0.01%
+5,136
New +$65.4K
MGNX icon
1125
MacroGenics
MGNX
$235M
$63K ﹤0.01%
+2,958
New +$63.1K

Similar funds

Pacer Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Pacer Advisors held 1,302 positions worth $2.66B, up 20% from $2.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Pacer Advisors deployed $395M of net new capital in Q3 2018, opening 172 new positions and adding to 969 existing holdings. Its largest new stake was VMware, Inc: 19,828 shares worth $3.09M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $3.26M trimmed.

  • Pacer Advisors's largest Q3 2018 buy was VMware, Inc: 19,828 shares worth $3.09M.
  • Pacer Advisors added most to Amazon in Q3 2018, an estimated $18.9M increase.
  • Pacer Advisors's biggest Q3 2018 reduction was Wellcare Health Plans, Inc., cutting an estimated $3.26M.
  • Pacer Advisors fully exited BASF AKTIENGESELLT ADS(RP1 ORD in Q3 2018, selling an estimated $7.2M.
  • Pacer Advisors's ten largest holdings make up 18% of its $2.66B portfolio in Q3 2018.
  • Pacer Advisors opened 172 new positions and closed 109 in Q3 2018.
  • Pacer Advisors's portfolio value rose 20% quarter-over-quarter to $2.66B.

Based on Pacer Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.